From the development to the clinical application of a questionnaire on the quality of life in dialysis. The experience of the Italian Collaborative DIA-QOL (Dialysis-Quality of Life) Group

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 1, 1998, Pages 70-75

  Mingardi, G ^a   Marchesi, D ^a   Perticucci, E ^a   Rota, S ^a   Tiraboschi, G ^a   Cornalba, L ^b   Brunzieri, C ^b   Foroni, I ^b   Lupi, G ^b   Cortinovis, E ^c   Ondei, P ^c   Alongi, G ^d   Lorenz, M ^d   Apolone, G ^e   Mosconi, P ^e   Ruggiata, R ^e  

^a OSPEDALI RIUNITI   (Italy)

^b Ospedale Predabissi   (Italy)

^c Policlin S Pietro Ponte S Pietro   (Italy)

^d Policlinico San Marco   (Italy)

^e MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ALBUMIN BLOOD LEVEL; CHRONIC DISEASE; CONFERENCE PAPER; EMOTION; HEALTH STATUS; HEMODIALYSIS; HUMAN; ITALY; KIDNEY FAILURE; MORTALITY; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; UREMIA;

HEALTH STATUS; HUMANS; KIDNEY FAILURE, CHRONIC; QUALITY OF LIFE; QUESTIONNAIRES; RENAL REPLACEMENT THERAPY;

EID: 0031985896     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_1.70     Document Type: Conference Paper

References (38)

1. Testa MA, Simonson DC. Assessment of quality-of-life outcomes. N Engl J Med 1996; 334: 835-840
2. Rettig RA. Measuring functional and health-related quality of life in end-stage renal disease patients: the Institute of Medicine's efforts in perspective. Seminars in Dialysis 1995; 8: 198-200
3. Kutner NG. Assessing end-stage renal disease patients' functioning and well-being: measurement approaches and implications for clinical practice. Am J Kidney Dis 1994; 24: 321-333
4. Levinsky NG, Mesler DE. Measuring, managing and improving the quality of end-stage renal disease care. Am J Kidney Dis 1994; 24: 235-246
5. Consensus Development Conference Panel. Morbidity and mortality of renal dialysis: an NIH consensus conference statement. Ann Intern Med 1994; 121: 62 70
6. Kurtin P, Nissenson AR. Variation in end-stage renal disease patient outcomes: what we know, what should we know, and how do we find it out? J Am Soc Nephrol 1993; 3: 1738 1747
7. Eknoyan G, Levey AS, Beck GJ, Agodoa LV, Daugirdas JT. Kusek JW, Levin NW, Schulman G, for the HEMO Study Group. The Hemodialysis (HEMO) Study: rationale for selection of interventions. Seminars in Dialysis 1996; 9: 24-33
8. Blagg CR. The socioeconomic impact of rehabilitation. Am J Kidney Dis 1994; 24 [Suppl 1]: S17-S21
9. Porter GA. Assessing the outcome of rehabilitation in patients with end-stage renal disease. Am J Kidney Dis 1994; 24 [Suppl 1]: S22-S27
10. Editorial: Quality of life and clinical trials. Lancet 1995; 346: 1-2
11. Evans RW, Manninen LD, Garrison LP, Gary Hart L et al. The quality of life of patients with end-stage renal disease. N Engl J Med 1985; 312: 553-559
12. Churcill DN, Torrance GW, Taylor DW, Barnes CC, Ludwin D, Shimizu A, Smith EKM. Measurement of quality of life in endstage renal disease: the Time Trade-off approach. Clin Invest Med 1987; 10: 14-20
13. Bergner M, Bobbit RA, Carter WB, Gilson BS. The Sickness Impact Profile: development and final revision of a health status measure. Med Care 1981; 19: 787-805
14. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36): 1. Conceptual framework and item selection. Med Care 1992; 30: 473-483
15. McHorney CA, Ware JE, Raczek AE. The MOS 36-item shortform health survey (SF36): 2. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care 1993; 31: 247-263
16. Khan IH, Garrat AM, Kumar A, Cody DJ, Catto GRD, Edward N, MacLeod AM. Patients' perception of health on renal replacement therapy: evaluation using a new instrument. Nephrol Dial Transplant 1995; 10: 684-689
17. Aaronson NK, Acquadro C, Alonso J, Apolone G et al. International quality of life assessment (IQOLA) project. Qual Life Res 1992; 1: 349-351
18. Laupacis A, Pus N, Muirhead N, Wong C, Ferguson B, Keown P. Disease-specific questionnaire for patients with a renal transplant. Nephron 1993; 64: 226-231
19. Laupacis A, Muirhead N, Keown P, Wong C. A disease specific questionnaire for assessing quality of life in patients on hemodialysis. Nephron 1992; 60: 302-306
20. Laupacis A, Keown P, Pus N, Krueger H, Ferguson B. Wong C, Muirhead N. A study of the quality of life and cost-utility of renal transplantation. Kidney Int 1996; 50: 235-242
21. Churcill DN, Bird DR, Taylor DW, Beecroft ML, Gorman J, Wallace JE. Effect of high-flux hemodialysis on quality of life and neuropsychological function in chronic hemodialysis patients. Am J Nephrol 1992; 12: 412-418
22. Hays RD, Kallich JD, Mapes DL, Coons SJ, Carter WB. Development of the kidney disease quality of life (KDQOL) instrument. Qual Life Res 1994; 3: 329-338
23. The GIVIO Investigators. Impact of follow up testing on survival and health related quality of life in breast cancer patients. A multicenter randomized controlled trial. JAMA 1994; 271: 1587-1592
24. Bergamo Collaborative Dialysis Study Group. Acute intradialytic well-being: results of a clinical trial comparing polysulfone with cuprophan. Kidney Int 1991; 40: 714-719
25. Apolone G, Cifani S, Liberati MC, Mosconi P. The SF-36 health survey. Translation and validation in Italy (IQOLA Project) Medic (in press)
26. Nissenson AR. Measuring, managing and improving quality in end-stage renal disease treatment setting: peritoneal dialysis. Am J Kidney Dis 1994; 24: 368-375
27. Russel JD, Beecroft ML, Ludwin D, Churchill DN. The quality of life in renal transplantation. A prospective study. Transplantation 1992; 54: 656-660
28. Held PJ, Port FK, Wolfe RA, Stannard DC et al. The dose of hemodialysis and patient mortality. Kidney Int 1996; 50: 550-556
29. Owen WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329: 1001-1006
30. Evans RW, Rader B, Manninen DL and Cooperative Multicenter EPO Clinical Trial Group. The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. JAMA 1990; 263: 825-830
31. Wall SJ. Haemoglobin - is more better? Nephrol Dial Transplant 1995; 10 [Suppl 2]: 56-61
32. Moreno F, Lopez Gomez JM, Sanz-Guajardo D, Jofre R, Valderrabano F, on behalf of the Spanish Cooperative Renal Patients Quality of Life Study Group. Quality of life in dialysis patients. A Spanish multicentre study. Nephrol Dial Transplant 1996; 11 [Suppl 2]: 125-129
33. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P. Markers for survival in dialysis: a seven-year prospective study. Am J Kidney Dis 1995; 26: 209-219
34. Kurtin PS, Davies AR, Meyer KB, DeGiacomo JM, Kantz ME. Patient-based health status measures in outpatient dialysis. Early experiences in developing an outcomes assessment program. Med Care 1992; 30 [Suppl 5]: S136-S149
35. Harris LE, Luft FC, Rudy DW, Tierney WM. Clinical correlates of functional status in patients with chronic renal insufficiency. Am J Kidney Dis 1993; 21: 161 166
36. Meyer KB, Espindle DM, DeGiacomo JM, Jenuleson CS, Kurtin PS, Davies AR. Monitoring dialysis patients' health status. Am J Kidney Dis 1994; 24: 267-279
37. Gudex CM. Health-related quality of life in endstage renal failure. Qual Life Res 1995; 4: 359-366
38. Kimmel PL, Peterson RA, Weihs KL, Simmens SJ, Boyle DH, Cruz I, Umana WO, Alleyne S, Veis JH. Aspects of quality of life in hemodialysis patients. J Am Soc Nephrol 1995; 6: 1418-1426